These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 25416076

  • 1. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [Abstract] [Full Text] [Related]

  • 2. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L, Morar N, Kapiga S, Ramjee G, Hayes R.
    J Acquir Immune Defic Syndr; 2020 Dec 01; 85(4):458-465. PubMed ID: 33136745
    [Abstract] [Full Text] [Related]

  • 3. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA, Friedland BA, Morar NS, Katzen LL, Ramjee G, Mokgatle MM, Ahmed K.
    Cult Health Sex; 2015 Dec 01; 17(8):1004-20. PubMed ID: 25913101
    [Abstract] [Full Text] [Related]

  • 4. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
    J Int AIDS Soc; 2015 Dec 01; 18(1):20536. PubMed ID: 26700845
    [Abstract] [Full Text] [Related]

  • 5. Male engagement in women's microbicide use in Kenya: Navigating gender norms.
    Schuler SR, Bukusi E.
    Health Care Women Int; 2017 May 01; 38(5):507-519. PubMed ID: 28273003
    [Abstract] [Full Text] [Related]

  • 6. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Mar 01; 24(3):866-880. PubMed ID: 31111297
    [Abstract] [Full Text] [Related]

  • 7. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M, Palanee-Phillips T, O'Rourke S, Adewumi K, Tenza S, Mathebula F, Wagner D, Ayub A, Montgomery ET.
    AIDS Care; 2019 Jun 01; 31(6):660-666. PubMed ID: 30309246
    [Abstract] [Full Text] [Related]

  • 8. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, Schwartz K, Laborde N, Soto-Torres L.
    PLoS One; 2014 Jun 01; 9(2):e89118. PubMed ID: 24586534
    [Abstract] [Full Text] [Related]

  • 9. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M, Wilcher R, Montgomery ET, Pool R, Schuler S, Lenzi R, Friedland B.
    J Int AIDS Soc; 2014 Jun 01; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [Abstract] [Full Text] [Related]

  • 10. Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape.
    Hartmann M, Montgomery E, Stadler J, Laborde N, Magazi B, Mathebula F, van der Straten A.
    Cult Health Sex; 2016 Jun 01; 18(6):611-24. PubMed ID: 26551920
    [Abstract] [Full Text] [Related]

  • 11. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.
    Katz AWK, Mensch BS, Woeber K, Musara P, Etima J, van der Straten A.
    BMC Womens Health; 2019 Jan 25; 19(1):18. PubMed ID: 30683103
    [Abstract] [Full Text] [Related]

  • 12. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, VOICE-C Study Team.
    J Int AIDS Soc; 2014 Jan 25; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [Abstract] [Full Text] [Related]

  • 13. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
    Venables E, Stadler J.
    Cult Health Sex; 2012 Jan 25; 14(2):181-94. PubMed ID: 22085043
    [Abstract] [Full Text] [Related]

  • 14. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW, Kwena ZA, Harper CC, Cohen CR, Bukusi EA.
    Cult Health Sex; 2020 Jun 25; 22(6):660-674. PubMed ID: 31241426
    [Abstract] [Full Text] [Related]

  • 15. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, MTN-003D Study Team.
    J Int AIDS Soc; 2016 Jun 25; 19(1):20875. PubMed ID: 27247202
    [Abstract] [Full Text] [Related]

  • 16. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]

  • 17. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M, Lanham M, Palanee-Phillips T, Mathebula F, Tolley EE, Peacock D, Pascoe L, Zissette S, Roberts ST, Wagner D, Wilson E, Ayub A, Wilcher R, Montgomery ET, CHARISMA team.
    AIDS Educ Prev; 2019 Oct 01; 31(5):433-451. PubMed ID: 31550193
    [Abstract] [Full Text] [Related]

  • 18. Male partners' influence on women's acceptance and use of PrEP products across two high HIV-burdened districts in South Africa.
    Mbewe L, Govender E.
    Afr J AIDS Res; 2020 Jul 01; 19(2):93-100. PubMed ID: 32320329
    [Abstract] [Full Text] [Related]

  • 19. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM, Mansoor LE, Abdool Karim Q.
    AIDS Care; 2017 Jun 01; 29(6):734-740. PubMed ID: 27799005
    [Abstract] [Full Text] [Related]

  • 20. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM.
    AIDS Behav; 2017 May 01; 21(5):1361-1375. PubMed ID: 27317411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.